4.7 Article

The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ

期刊

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s12276-018-0162-6

关键词

-

资金

  1. Korea Mouse Phenotyping Project [2016M3A9D5A01952411]
  2. National Research Foundation of Korea (NRF) - Korean government (MSIP) [2017R1A2B2007378, 2014M3A9D8034464]
  3. NRF grant - Ministry of Education [2016R1A6A3A11932338]
  4. National Research Foundation of Korea [2016M3A9D5A01952411, 2017R1A2B2007378, 2014M3A9D8034464, 2016R1A6A3A11932338] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-dependent transcription factor that regulates adipocyte differentiation and glucose homeostasis. The transcriptional activity of PPAR gamma is regulated not only by ligands but also by post-translational modifications (PTMs). In this study, we demonstrate that a novel E3 ligase of PPAR., tripartite motif-containing 25 (TRIM25), directly induced the ubiquitination of PPAR gamma, leading to its proteasome-dependent degradation. During adipocyte differentiation, both TRIM25 mRNA and protein expression significantly decreased and negatively correlated with the expression of PPAR gamma. The stable expression of TRIM25 reduced PPAR gamma protein levels and suppressed adipocyte differentiation in 3T3-L1 cells. In contrast, the specific knockdown of TRIM25 increased PPAR gamma protein levels and stimulated adipocyte differentiation. Furthermore, TRIM25-knockout mouse embryonic fibroblasts (MEFs) exhibited an increased adipocyte differentiation capability compared with wild-type MEFs. Taken together, these data indicate that TRIM25 is a novel E3 ubiquitin ligase of PPAR gamma and that TRIM25 is a novel target for PPAR gamma-associated metabolic diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据